BIOGEN INC (BIIB) Stock Analyst Ratings
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 72% to BIIB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 172.86. This target is 24.72% above the current price.
BIIB was analyzed by 43 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about BIIB.
In the previous month the buy percentage consensus was at a similar level.
BIIB was analyzed by 43 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-01 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-27 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-12 | Needham | Reiterate | Hold -> Hold |
| 2025-06-12 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-06-12 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-05-07 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-05 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-02 | Needham | Reiterate | Hold -> Hold |
| 2025-05-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-02 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-29 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-29 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-25 | Needham | Reiterate | Hold -> Hold |
| 2025-04-23 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-16 | Needham | Reiterate | Hold -> Hold |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-04 | Argus Research | Downgrade | Buy -> Hold |
| 2025-02-18 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-02-13 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-13 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-02-13 | Needham | Reiterate | Hold -> Hold |